Skip to main content
Erschienen in: European Journal of Nuclear Medicine and Molecular Imaging 1/2023

11.09.2023 | Original Article

The feasibility of quantitative assessment of dynamic 18F-fluorodeoxyglucose PET in Takayasu’s arteritis: a pilot study

verfasst von: Yanhua Duan, Keyu Zan, Minjie Zhao, Yee Ling Ng, Hui Li, Min Ge, Leiying Chai, Xiao Cui, Wenjin Quan, Kun Li, Yun Zhou, Li Chen, Ximing Wang, Zhaoping Cheng

Erschienen in: European Journal of Nuclear Medicine and Molecular Imaging | Ausgabe 1/2023

Einloggen, um Zugang zu erhalten

Abstract

Purpose

PET has been demonstrated to be sensitive for detecting active inflammation in Takayasu’s arteritis (TAK) patients, but semi-quantitative-based assessment may be susceptible to various biological and technical factors. Absolute quantification via dynamic PET (dPET) may provide a more reliable and quantitative assessment of TAK-active arteries. The purpose of this study was to investigate the feasibility and efficacy of dPET in quantifying TAK-active arteries compared to static PET.

Materials and methods

This prospective study enrolled 10 TAK-active patients (fulfilled the NIH criteria) and 5 control participants from March to October 2022. One-hour dPET scan (all TAK and control participants) and delayed static PET scan at 2-h (all TAK patients) were acquired. For 1-h static PET, summed images from 50 to 60 min of the dPET were extracted. PET parameters derived from 1- and 2-h static PET including SUV (SUV1H and SUV2H), target-to-background ratio (TBR) (TBR1H and TBR2H), net influx rate (Ki), and TBRKi extracted from dPET were obtained. The detectability of TAK-active arteries was compared among different scanning methods using the generalized estimating equation (GEE) with a logistic regression with repeated measures, and the GEE with gamma distribution and log link function was used to evaluate the different study groups or scanning methods.

Results

Based on the disease states, 5 cases of TAK were classified as untreated and relapsed, respectively. The SUVmax on 2-h PET was higher than that on 1-h PET in the untreated patients (P < 0.05). However, no significant differences were observed in the median SUVmax between 1-h PET and 2-h PET in the relapsed patients (P > 0.05). The TBRKi was significantly higher than both TBR1H and TBR2H (all P < 0.001). Moreover, the detectability of TAK-active arteries by dPET-derived Ki was significantly higher than 1-h and 2-h PET (all P < 0.001). Significant differences were observed in Kimax, SUVmax-1H, TBR1H, and TBRKi among untreated, relapsed, and control groups (all P < 0.05).

Conclusions

Absolute quantitative assessment by dPET provides an improved sensitivity and detectability in both visualization and quantification of TAK-active arteries. This elucidates the clinical significance of dPET in the early detection of active inflammation and monitoring recurrence.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Ishikawa K, Maetani S. Long-term outcome for 120 Japanese patients with Takayasu’s disease. Clinical and statistical analyses of related prognostic factors. Circulation. 1994;90:1855–60.CrossRefPubMed Ishikawa K, Maetani S. Long-term outcome for 120 Japanese patients with Takayasu’s disease. Clinical and statistical analyses of related prognostic factors. Circulation. 1994;90:1855–60.CrossRefPubMed
2.
Zurück zum Zitat Grayson PC, Ponte C, Suppiah R, et al. 2022 American College of Rheumatology/EULAR classification criteria for Takayasu arteritis. Ann Rheum Dis. 2022;81(12):1654–60.CrossRefPubMed Grayson PC, Ponte C, Suppiah R, et al. 2022 American College of Rheumatology/EULAR classification criteria for Takayasu arteritis. Ann Rheum Dis. 2022;81(12):1654–60.CrossRefPubMed
3.
Zurück zum Zitat de Souza AW, de Carvalho JF. Diagnostic and classification criteria of Takayasu arteritis. J Autoimmun. 2014;48–49:79–83.CrossRefPubMed de Souza AW, de Carvalho JF. Diagnostic and classification criteria of Takayasu arteritis. J Autoimmun. 2014;48–49:79–83.CrossRefPubMed
4.
Zurück zum Zitat Vaidyanathan S, Patel CN, Scarsbrook AF, Chowdhury FU. FDG PET/CT in infection and inflammation—current and emerging clinical applications. Clin Radiol. 2015;70(7):787–800.CrossRefPubMed Vaidyanathan S, Patel CN, Scarsbrook AF, Chowdhury FU. FDG PET/CT in infection and inflammation—current and emerging clinical applications. Clin Radiol. 2015;70(7):787–800.CrossRefPubMed
5.
Zurück zum Zitat Einspieler I, Thürmel K, Pyka T, et al. Imaging large vessel vasculitis with fully integrated PET/MRI: A pilot study. Eur J Nucl Med Mol Imaging. 2015;42(7):1012–24.CrossRefPubMed Einspieler I, Thürmel K, Pyka T, et al. Imaging large vessel vasculitis with fully integrated PET/MRI: A pilot study. Eur J Nucl Med Mol Imaging. 2015;42(7):1012–24.CrossRefPubMed
6.
Zurück zum Zitat Gheysens O, Jamar F, Glaudemans AWJM, Yildiz H, van der Geest KSM. Semi-quantitative and quantitative [18F]FDG-PET/CT indices for diagnosing large vessel vasculitis: A critical review. Diagnostics (Basel). 2021;11(12):2355.CrossRefPubMed Gheysens O, Jamar F, Glaudemans AWJM, Yildiz H, van der Geest KSM. Semi-quantitative and quantitative [18F]FDG-PET/CT indices for diagnosing large vessel vasculitis: A critical review. Diagnostics (Basel). 2021;11(12):2355.CrossRefPubMed
7.
Zurück zum Zitat Adams MC, Turkington TG, Wilson JM, Wong TZ. A systematic review of the factors affecting accuracy of SUV measurements. AJR Am J Roentgenol. 2010;195:310–20.CrossRefPubMed Adams MC, Turkington TG, Wilson JM, Wong TZ. A systematic review of the factors affecting accuracy of SUV measurements. AJR Am J Roentgenol. 2010;195:310–20.CrossRefPubMed
8.
Zurück zum Zitat Choi JY, Yang J, Noworolski SM, et al. 18F fluorocholine dynamic time-of-flight PET/MR imaging in patients with newly diagnosed intermediate- to high-risk prostate cancer: Initial clinical-pathologic comparisons. Radiology. 2017;282(2):429–36.CrossRefPubMed Choi JY, Yang J, Noworolski SM, et al. 18F fluorocholine dynamic time-of-flight PET/MR imaging in patients with newly diagnosed intermediate- to high-risk prostate cancer: Initial clinical-pathologic comparisons. Radiology. 2017;282(2):429–36.CrossRefPubMed
9.
Zurück zum Zitat Wardak M, Sonni I, Fan AP, et al. 18F-FSPG PET/CT imaging of system xC- transporter activity in patients with primary and metastatic brain tumors. Radiology. 2022;303(3):620–31.CrossRefPubMed Wardak M, Sonni I, Fan AP, et al. 18F-FSPG PET/CT imaging of system xC- transporter activity in patients with primary and metastatic brain tumors. Radiology. 2022;303(3):620–31.CrossRefPubMed
10.
11.
Zurück zum Zitat Spencer BA, Berg E, Schmall JP, et al. Performance evaluation of the uEXPLORER total-body PET/CT scanner based on NEMA NU 2–2018 with additional tests to characterize pet scanners with a long axial field of view. J Nucl Med. 2021;62(6):861–70.CrossRefPubMedPubMedCentral Spencer BA, Berg E, Schmall JP, et al. Performance evaluation of the uEXPLORER total-body PET/CT scanner based on NEMA NU 2–2018 with additional tests to characterize pet scanners with a long axial field of view. J Nucl Med. 2021;62(6):861–70.CrossRefPubMedPubMedCentral
12.
Zurück zum Zitat Cherry SR, Badawi RD, Karp JS, Moses WW, Price P, Jones T. Total-body imaging: Transforming the role of positron emission tomography. Sci Transl Med. 2017;9(381):eaaf6169.CrossRefPubMedPubMedCentral Cherry SR, Badawi RD, Karp JS, Moses WW, Price P, Jones T. Total-body imaging: Transforming the role of positron emission tomography. Sci Transl Med. 2017;9(381):eaaf6169.CrossRefPubMedPubMedCentral
13.
Zurück zum Zitat Sari H, Mingels C, Alberts I, et al. First results on kinetic modelling and parametric imaging of dynamic 18F-FDG datasets from a long axial FOV PET scanner in oncological patients. Eur J Nucl Med Mol Imaging. 2022;49(6):1997–2009.CrossRefPubMed Sari H, Mingels C, Alberts I, et al. First results on kinetic modelling and parametric imaging of dynamic 18F-FDG datasets from a long axial FOV PET scanner in oncological patients. Eur J Nucl Med Mol Imaging. 2022;49(6):1997–2009.CrossRefPubMed
14.
Zurück zum Zitat Duan Y, Wang X, Cheng Z. Immunoglobulin G4-related aortitis/periaortitis: Total-body 18F-fluorodeoxyglucose positron emission tomography dynamic imaging. Circ Cardiovasc Imaging. 2023;16(3): e014176.PubMed Duan Y, Wang X, Cheng Z. Immunoglobulin G4-related aortitis/periaortitis: Total-body 18F-fluorodeoxyglucose positron emission tomography dynamic imaging. Circ Cardiovasc Imaging. 2023;16(3): e014176.PubMed
15.
Zurück zum Zitat Sharma BK, Jain S, Suri S, Numano F. Diagnostic criteria for Takayasu arteritis. Int J Cardiol. 1996;54:S141–7.CrossRefPubMed Sharma BK, Jain S, Suri S, Numano F. Diagnostic criteria for Takayasu arteritis. Int J Cardiol. 1996;54:S141–7.CrossRefPubMed
16.
Zurück zum Zitat Arend WP, Michel BA, Bloch DA, et al. The American College of Rheumatology 1990 criteria for the classification of Takayasu arteritis. Arthritis Rheum. 1990;33:1129–34.CrossRefPubMed Arend WP, Michel BA, Bloch DA, et al. The American College of Rheumatology 1990 criteria for the classification of Takayasu arteritis. Arthritis Rheum. 1990;33:1129–34.CrossRefPubMed
17.
Zurück zum Zitat Kerr GS, Hallahan CW, Giordano J, et al. Takayasu arteritis. Ann Intern Med. 1994;120(11):919–29.CrossRefPubMed Kerr GS, Hallahan CW, Giordano J, et al. Takayasu arteritis. Ann Intern Med. 1994;120(11):919–29.CrossRefPubMed
19.
Zurück zum Zitat Grayson PC, Alehashemi S, Bagheri AA, et al. 18 F-fluorodeoxyglucose-positron emission tomography as an imaging biomarker in a prospective, longitudinal cohort of patients with large vessel vasculitis. Arthritis Rheumatol. 2018;70(3):439–49.CrossRefPubMedPubMedCentral Grayson PC, Alehashemi S, Bagheri AA, et al. 18 F-fluorodeoxyglucose-positron emission tomography as an imaging biomarker in a prospective, longitudinal cohort of patients with large vessel vasculitis. Arthritis Rheumatol. 2018;70(3):439–49.CrossRefPubMedPubMedCentral
20.
Zurück zum Zitat Incerti E, Tombetti E, Fallanca F, et al. 18F-FDG PET reveals unique features of large vessel inflammation in patients with Takayasu’s arteritis. Eur J Nucl Med Mol Imaging. 2017;44(7):1109–18.CrossRefPubMed Incerti E, Tombetti E, Fallanca F, et al. 18F-FDG PET reveals unique features of large vessel inflammation in patients with Takayasu’s arteritis. Eur J Nucl Med Mol Imaging. 2017;44(7):1109–18.CrossRefPubMed
21.
Zurück zum Zitat Quinn KA, Rosenblum JS, Rimland CA, Gribbons KB, Ahlman MA, Grayson PC. Imaging acquisition technique influences interpretation of positron emission tomography vascular activity in large-vessel vasculitis. Semin Arthritis Rheum. 2020;50(1):71–6.CrossRefPubMed Quinn KA, Rosenblum JS, Rimland CA, Gribbons KB, Ahlman MA, Grayson PC. Imaging acquisition technique influences interpretation of positron emission tomography vascular activity in large-vessel vasculitis. Semin Arthritis Rheum. 2020;50(1):71–6.CrossRefPubMed
22.
Zurück zum Zitat Martínez-Rodríguez I, del Castillo-Matos R, Quirce R, et al. Comparison of early (60 min) and delayed (180 min) acquisition of 18F-FDG PET/CT in large vessel vasculitis. Rev Esp Med Nucl Imagen Mol. 2013;32(4):222–6.PubMed Martínez-Rodríguez I, del Castillo-Matos R, Quirce R, et al. Comparison of early (60 min) and delayed (180 min) acquisition of 18F-FDG PET/CT in large vessel vasculitis. Rev Esp Med Nucl Imagen Mol. 2013;32(4):222–6.PubMed
23.
Zurück zum Zitat Dias AH, Pedersen MF, Danielsen H, Munk OL, Gormsen LC. . Clinical feasibility and impact of fully automated multiparametric PET imaging using direct Patlak reconstruction: Evaluation of 103 dynamic whole-body 18F-FDG PET/CT scans [published correction appears in Eur J Nucl Med Mol Imaging. 2021 Feb 13;]. Eur J Nucl Med Mol Imaging. 2021;48(3):837–50.CrossRefPubMed Dias AH, Pedersen MF, Danielsen H, Munk OL, Gormsen LC. . Clinical feasibility and impact of fully automated multiparametric PET imaging using direct Patlak reconstruction: Evaluation of 103 dynamic whole-body 18F-FDG PET/CT scans [published correction appears in Eur J Nucl Med Mol Imaging. 2021 Feb 13;]. Eur J Nucl Med Mol Imaging. 2021;48(3):837–50.CrossRefPubMed
24.
Zurück zum Zitat Cheng G, Alavi A, Lim E, Werner TJ, Del Bello CV, Akers SR. Dynamic changes of FDG uptake and clearance in normal tissues. Mol Imaging Biol. 2013;15(3):345–52.CrossRefPubMed Cheng G, Alavi A, Lim E, Werner TJ, Del Bello CV, Akers SR. Dynamic changes of FDG uptake and clearance in normal tissues. Mol Imaging Biol. 2013;15(3):345–52.CrossRefPubMed
25.
Zurück zum Zitat Tezuka D, Haraguchi G, Ishihara T, et al. Role of FDG PET-CT in Takayasu arteritis: Sensitive detection of recurrences. JACC Cardiovasc Imaging. 2012;5(4):422–9.CrossRefPubMed Tezuka D, Haraguchi G, Ishihara T, et al. Role of FDG PET-CT in Takayasu arteritis: Sensitive detection of recurrences. JACC Cardiovasc Imaging. 2012;5(4):422–9.CrossRefPubMed
26.
Zurück zum Zitat Houshmand S, Salavati A, Segtnan EA, Grupe P, Høilund-Carlsen PF, Alavi A. Dual-time-point imaging and delayed-time-point fluorodeoxyglucose-PET/computed tomography imaging in various clinical settings. PET Clin. 2016;11(1):65–84.CrossRefPubMed Houshmand S, Salavati A, Segtnan EA, Grupe P, Høilund-Carlsen PF, Alavi A. Dual-time-point imaging and delayed-time-point fluorodeoxyglucose-PET/computed tomography imaging in various clinical settings. PET Clin. 2016;11(1):65–84.CrossRefPubMed
27.
Zurück zum Zitat Shinya T, Otomi Y, Kubo M, et al. Preliminary clinical assessment of dynamic 18F-fluorodeoxyglucose positron emission tomography/computed tomography for evaluating lymph node metastasis in patients with lung cancer: A prospective study. Ann Nucl Med. 2019;33(6):414–23.CrossRefPubMed Shinya T, Otomi Y, Kubo M, et al. Preliminary clinical assessment of dynamic 18F-fluorodeoxyglucose positron emission tomography/computed tomography for evaluating lymph node metastasis in patients with lung cancer: A prospective study. Ann Nucl Med. 2019;33(6):414–23.CrossRefPubMed
28.
Zurück zum Zitat Dimitrakopoulou-Strauss A, Pan L, Sachpekidis C. Kinetic modeling and parametric imaging with dynamic PET for oncological applications: General considerations, current clinical applications, and future perspectives. Eur J Nucl Med Mol Imaging. 2021;48(1):21–39.CrossRefPubMed Dimitrakopoulou-Strauss A, Pan L, Sachpekidis C. Kinetic modeling and parametric imaging with dynamic PET for oncological applications: General considerations, current clinical applications, and future perspectives. Eur J Nucl Med Mol Imaging. 2021;48(1):21–39.CrossRefPubMed
29.
Zurück zum Zitat Fu F, Li X, Wu Y, et al. Total-body dynamic PET/CT of micro-metastatic lymph node in a patient with lung cancer. Eur J Nucl Med Mol Imaging. 2021;48:1678–9.CrossRefPubMed Fu F, Li X, Wu Y, et al. Total-body dynamic PET/CT of micro-metastatic lymph node in a patient with lung cancer. Eur J Nucl Med Mol Imaging. 2021;48:1678–9.CrossRefPubMed
30.
Zurück zum Zitat Kobayashi Y, Ishii K, Oda K, et al. Aortic wall inflammation due to Takayasu arteritis imaged with 18F-FDG PET coregistered with enhanced CT. J Nucl Med. 2005;46(6):917–22.PubMed Kobayashi Y, Ishii K, Oda K, et al. Aortic wall inflammation due to Takayasu arteritis imaged with 18F-FDG PET coregistered with enhanced CT. J Nucl Med. 2005;46(6):917–22.PubMed
31.
Zurück zum Zitat Incerti E, Tombetti E, Fallanca F, et al. (18)F-FDG PET reveals unique features of large vessel inflammation in patients with Takayasu’s arteritis. Eur J Nucl Med Mol Imaging. 2017;44:1109–18.CrossRefPubMed Incerti E, Tombetti E, Fallanca F, et al. (18)F-FDG PET reveals unique features of large vessel inflammation in patients with Takayasu’s arteritis. Eur J Nucl Med Mol Imaging. 2017;44:1109–18.CrossRefPubMed
32.
Zurück zum Zitat Barra L, Kanji T, Malette J, Pagnoux C; CanVasc. Imaging modalities for the diagnosis and disease activity assessment of Takayasu’s arteritis: A systematic review and meta-analysis. Autoimmun Rev. 2018;17(2):175–187. Barra L, Kanji T, Malette J, Pagnoux C; CanVasc. Imaging modalities for the diagnosis and disease activity assessment of Takayasu’s arteritis: A systematic review and meta-analysis. Autoimmun Rev. 2018;17(2):175–187.
Metadaten
Titel
The feasibility of quantitative assessment of dynamic 18F-fluorodeoxyglucose PET in Takayasu’s arteritis: a pilot study
verfasst von
Yanhua Duan
Keyu Zan
Minjie Zhao
Yee Ling Ng
Hui Li
Min Ge
Leiying Chai
Xiao Cui
Wenjin Quan
Kun Li
Yun Zhou
Li Chen
Ximing Wang
Zhaoping Cheng
Publikationsdatum
11.09.2023
Verlag
Springer Berlin Heidelberg
Erschienen in
European Journal of Nuclear Medicine and Molecular Imaging / Ausgabe 1/2023
Print ISSN: 1619-7070
Elektronische ISSN: 1619-7089
DOI
https://doi.org/10.1007/s00259-023-06429-4

Weitere Artikel der Ausgabe 1/2023

European Journal of Nuclear Medicine and Molecular Imaging 1/2023 Zur Ausgabe